Literature DB >> 3871201

Fab-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia.

D J Christie, P C Mullen, R H Aster.   

Abstract

Platelets coated with quinine- or quinidine-induced antibodies form rosettes around protein A-Sepharose beads and normal platelets form rosettes about protein A-Sepharose beads coated with these antibodies. These reactions occurred only in the presence of sensitizing drug. Platelets also formed rosettes about protein A-Sepharose beads coated with an anti-PIA1 antibody, but drug was not required. Formation of rosettes between antibody-coated platelets and protein A-Sepharose was inhibited by F(ab')2 fragments of goat antibody specific for the Fc portion of human IgG, while rosette formation between antibody-coated protein A-Sepharose and platelets was inhibited by F(ab')2 fragments directed against the F(ab')2 portion of the IgG molecule. Since binding of IgG to protein A is known to occur via the Fc region, these findings suggest that binding of drug-induced antibodies to platelets occurs at the Fab domains of the IgG molecule.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871201      PMCID: PMC423442          DOI: 10.1172/JCI111691

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  13 in total

1.  Cyclic AMP metabolism in cholesterol-rich platelets.

Authors:  A K Sinha; S J Shattil; R W Colman
Journal:  J Biol Chem       Date:  1977-05-25       Impact factor: 5.157

2.  Coombs'-test positivity induced by drugs. Mechanisms of immunologic reactions and red cell destruction.

Authors:  J D Croft; S N Swisher; B C Gilliland; R F Bakemeier; J P Leddy; R I Weed
Journal:  Ann Intern Med       Date:  1968-01       Impact factor: 25.391

3.  A platelet and granulocyte membrane defect in paroxysmal nocturnal hemoglobinuria: usefulness for the detection of platelet antibodies.

Authors:  R H Aster; S E Enright
Journal:  J Clin Invest       Date:  1969-07       Impact factor: 14.808

4.  Structural features of the quinidine and quinine molecules necessary for binding of drug-induced antibodies to human platelets.

Authors:  D J Christie; R W Weber; P C Mullen; J M Cook; R H Aster
Journal:  J Lab Clin Med       Date:  1984-11

5.  Studies on quinine- and quinidine-dependent antibodies against platelets and their reaction with platelets in the Bernard-Soulier syndrome.

Authors:  E F van Leeuwen; C P Engelfriet; A E von dem Borne
Journal:  Br J Haematol       Date:  1982-08       Impact factor: 6.998

6.  The use of a protein A-Sepharose column in the detection of platelet-associated IgG.

Authors:  D J McVeigh; C N Chesterman
Journal:  Thromb Res       Date:  1981-09-15       Impact factor: 3.944

7.  A new elution procedure using chloroform, a nonflammable organic solvent.

Authors:  D R Branch; A L Hian; L D Petz
Journal:  Vox Sang       Date:  1982-01       Impact factor: 2.144

8.  Direct quantitation of platelet-associated IgG by electroimmunoassay.

Authors:  T J Kunicki; M B Koenig; S M Kristopeit; R H Aster
Journal:  Blood       Date:  1982-07       Impact factor: 22.113

9.  Quinidine-induced thrombocytopenia and leukopenia: demonstration and characterization of distinct antiplatelet and antileukocyte antibodies.

Authors:  B H Chong; M C Berndt; J Koutts; P A Castaldi
Journal:  Blood       Date:  1983-12       Impact factor: 22.113

10.  Drug-antibody-platelet interaction in quinine- and quinidine-induced thrombocytopenia.

Authors:  D J Christie; R H Aster
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

View more
  11 in total

Review 1.  Immunotoxic side-effects of drug therapy.

Authors:  J A Mitchell; E M Gillam; L A Stanley; E Sim
Journal:  Drug Saf       Date:  1990 May-Jun       Impact factor: 5.606

2.  Binding of quinine- and quinidine-dependent drug antibodies to platelets is mediated by the Fab domain of the immunoglobulin G and is not Fc dependent.

Authors:  M E Smith; D M Reid; C E Jones; J V Jordan; C A Kautz; N R Shulman
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

3.  Immune thrombocytopenia associated with hemorrhagic diathesis due to ibuprofen administration.

Authors:  T Meyer; C Herrmann; V Wiegand; B Mathias; V Kiefel; C Mueller-Eckhardt
Journal:  Clin Investig       Date:  1993-05

4.  Mechanism of quinine-dependent monoclonal antibody binding to platelet glycoprotein IIb/IIIa.

Authors:  Daniel W Bougie; Julie Peterson; Mark Rasmussen; Richard H Aster
Journal:  Blood       Date:  2015-09-09       Impact factor: 22.113

Review 5.  Drug-induced immune thrombocytopenia.

Authors:  Patricia M L A van den Bemt; Ronald H B Meyboom; Antoine C G Egberts
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

6.  Patients with quinine-induced immune thrombocytopenia have both "drug-dependent" and "drug-specific" antibodies.

Authors:  Daniel W Bougie; Peter R Wilker; Richard H Aster
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

7.  Structural basis for quinine-dependent antibody binding to platelet integrin αIIbβ3.

Authors:  Jianghai Zhu; Jieqing Zhu; Daniel W Bougie; Richard H Aster; Timothy A Springer
Journal:  Blood       Date:  2015-08-17       Impact factor: 22.113

Review 8.  Drug-induced thrombocytopenia.

Authors:  Gian Paolo Visentin; Chao Yan Liu
Journal:  Hematol Oncol Clin North Am       Date:  2007-08       Impact factor: 3.722

Review 9.  Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management.

Authors:  R H Aster; B R Curtis; J G McFarland; D W Bougie
Journal:  J Thromb Haemost       Date:  2009-04-02       Impact factor: 5.824

10.  Octreotide-induced thrombocytopenia: a case report.

Authors:  Armin Rashidi; Nahid Rizvi
Journal:  J Med Case Rep       Date:  2011-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.